Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Lung Cancer. 2015 Sep 15;90(2):182–190. doi: 10.1016/j.lungcan.2015.09.014

Figure 2. Effect of shRNA targeting of STAT3 on STAT3 gene targets and A549 cell proliferation.

Figure 2

Total RNA (A) or protein (B) was extracted from A549 cells stably transfected with either control shRNA or 2 distinct STAT3 shRNA constructs and used to determine levels of STAT3 mRNA by quantitative RT-PCR (A) or levels of pSTAT3, total STAT3 and GAPDH protein using Luminex beads (B); mean ± SD of 3 separate determinations are shown; *, p<0.003 for each. C) Cell proliferation in A549 cells stably transfected with either control shRNA or 2 distinct STAT3 shRNA constructs was determined by MTT assay using either anchorage-dependent (left panel) and anchorage- independent (right panel) conditions. Data shown are mean ± SD of 3 determinations; *, p<0.0001 for each. D) Levels of four STAT3 downstream gene targets were determined in total RNA of A549 cells stably transfected with either control shRNA or 2 distinct STAT3 shRNA constructs using quantitative RT-PCR. Data shown are mean ± SD of 3 determinations; *, p<0.02, p<0.04, p<0.03 and p<0.02, as shown.